The best of EcoWatch, right in your inbox. Sign up for our email newsletter!
EcoWatch Daily Newsletter
In a significant win in the fight to save antibiotics, McDonald's—the largest and most iconic burger chain on the planet—announced Tuesday that it will address the use of antibiotics in its international supply chain for beef by 2021.
Tawatchai Prakobkit / EyeEm / Getty Images
Sanderson Farms announced Friday that it will stop unnecessarily administering two medically important antibiotics—the only two it reports using—in its chickens by March 1, 2019. The company will use the two antibiotics only when treating ailing animals or to control diseases in flocks with some sick birds. "This is a welcome change of heart and good news for people's health," said David Wallinga, senior health officer at NRDC. "To inspire consumer confidence, however, these new pledges will need to be independently verified."
By Erik D. Olson and Lena Brook
We live in partisan times, as anyone who had to sit through Thanksgiving dinner with distant relatives can probably attest. But even your crazy uncle would agree that the safety of our food shouldn't be a partisan issue. No one wants their child to get sick from eating a hamburger, chicken, or—in the case of the current E. coli outbreak—romaine lettuce. Yet last week's empty Thanksgiving salad bowls are a harbinger of what's to come if our federal government does not start taking food safety seriously.
Those bacteria were resistant to at least one of 14 antibiotics tested for by the National Antimicrobial Resistance Monitoring System, a federal public health partnership.
By Rob Minto
The global superbug crisis is a complicated, long-term problem. The video below explains how it starts, spreads and its impact. But there are many other—sometimes surprising—aspects to this crisis.
There is one key way in which superbugs start. Whether it is in animals or humans, the initial point is where antibiotics kill off drug-susceptible bacteria, leaving drug-resistant bacteria to multiply.
By Madlen Davies and Sam Loewenberg
Many of the world's leading drug manufacturers may be leaking antibiotics from their factories into the environment, according to a new report from a drug industry watchdog. This risks creating more superbugs.
The report surveyed household-name pharmaceutical giants like GSK, Novartis and Roche as well as generic companies which make non-branded products for the NHS and other health systems.
A breakthrough in antibiotic resistance was reported last week. Scientists had re-engineered the drug vancomycin—used against extremely resistant infections including MRSA—to make it stronger and stop bugs becoming immune to it. Vancomycin has been prescribed for 60 years and is a highly effective antibiotic—yet in some countries bacteria are developing resistance.
By Madlen Davies
Industrial pollution from Indian pharmaceutical companies making medicines for nearly all the world's major drug companies is fueling the creation of deadly superbugs, suggests new research. Global health authorities have no regulations in place to stop this happening.
Following a four-month battle for his life, Chris Linaman committed to sharing his story to help raise awareness about the growing threat posed by antibiotic-resistant bacteria. As executive chef at a large medical center, he is also driving change at an institutional level, harnessing his purchasing power to support the responsible use of antibiotics in food animals.